New York, New York, United States Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Paidy. Among the most successful fund investment fields, there are Payments, Financial Services.
Deals in the range of more than 100 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2019.
The typical case for the fund is to invest in rounds with 4 participants. Despite the JS Capital Management, startups are often financed by Visa, Sumitomo Mitsui Trust Bank, Sumitomo Mitsui Banking Corporation. The meaningful sponsors for the fund in investment in the same round are Venrock, Tybourne Capital Management, Soros Capital Management.
The overall number of key employees were 2.
Related Funds
| Fund Name | Location |
| Advenio Capital Management | Connecticut, Greenwich, United States |
| Applebee's | California, Glendale, United States |
| BDC | County Dublin, Dublin, Ireland |
| Bestseller Group | - |
| ClearArc Capital | Cincinnati, Ohio, United States |
| Constant Capital | Accra, Ghana, Greater Accra |
| Danfeng Venture Capital | China, Shanghai |
| Energia | Hiroshima, Hiroshima Prefecture, Japan |
| Grand Prix Capital | Australia, Bondi, New South Wales |
| HU Investments | Montclair, New Jersey, United States |
| New Medical Technologies | - |
| Renjing Yatang Cultural Communication | Beijing, Beijing, China |
| Ripple | California, San Francisco, United States |
| Senmed Medical Ventures | - |
| Shanghai Boyong Asset Management | China, Shanghai |
| The Global Emerging Markets Group | New York, New York, United States |
| The Motley Fool | Alexandria, United States, Virginia |
| Xinhua Huijin | Beijing, Beijing, China |
| Zhang Shi Touzi | China, Zhejiang, Zhuji |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Element Biosciences | $276M | 29 Jun 2021 | San Diego, California, United States | ||
Paidy | $83M | 01 Nov 2019 | Chiba Prefecture |
– Element Biosciences from San Diego develops DNA sequencing platform.
– The company closed a $276m Series C financing.
– Backers included new investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price and existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock.
– The new investment will be used to scale commercial organization in anticipation of the launch of its next-generation sequencing solution.
– Paidy Inc. (Japan) has raised US$120m in Series D funding round.
– The round was led by JS Capital Management LLC, Soros Capital Management LLC, Tybourne Capital Management Ltd., and Wellington Management.
– Since late 2020, Paidy has additionally completed the loan facilities set up by upsizing the warehouse facility with Goldman Sachs, newly establishing the secured loan facility with Sumitomo Mitsui Banking Corporation and the other warehouse facility through the syndication led by Mizuho Bank, Ltd.
– This capital increase and additional debt financing from the financial institutions bring total capital raising since the company’s founding to US$585m (of which, equity is US$337m, one of the largest amounts of funding ever raised by a startup in Japan).
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Element Biosciences | $276M | 29 Jun 2021 | San Diego, California, United States | ||
Paidy | $83M | 01 Nov 2019 | Chiba Prefecture |
